Search Results - "Ostor, A" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

by Emery, P, Gottenberg, J E, Rubbert-Roth, A, Sarzi-Puttini, P, Choquette, D, Taboada, V M Martínez, Barile-Fabris, L, Moots, R J, Ostor, A, Andrianakos, A, Gemmen, E, Mpofu, C, Chung, C, Gylvin, L Hinsch, Finckh, A
Published in Annals of the rheumatic diseases (01.06.2015)

Get full text

Journal Article

AB1232 Estimating the economic value of a patient support program in rheumatoid arthritis in the united kingdom

AB1232 Estimating the economic value of a patient support program in rheumatoid arthritis in the united kingdom

by Ostor, A., Garg, V., Yang, M., Chamberlain, C., Skup, M.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

POS0907 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

POS0907 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

by Deodhar, A., Baraliakos, X., Mcinnes, I., De Vlam, K., Bessette, L., Maniccia, A., Lippe, R., Saffore, C., Gao, T., Song, I. H., Ostor, A.
Published in Annals of the rheumatic diseases (01.06.2021)

Get full text

Journal Article

OP0228 EFFICACY AND SAFETY OF RISANKIZUMAB FOR ACTIVE PSORIATIC ARTHRITIS, INCLUDING PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC THERAPIES: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, KEEPSAKE 2 TRIAL

OP0228 EFFICACY AND SAFETY OF RISANKIZUMAB FOR ACTIVE PSORIATIC ARTHRITIS, INCLUDING PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC THERAPIES: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, KEEPSAKE 2 TRIAL

by Ostor, A., Van den Bosch, F., Papp, K., Asnal, C., Blanco, R., Aelion, J., Alperovich, G., Zhang, Y., Wang, Z., Soliman, A. M., Eldred, A., Kivitz, A.
Published in Annals of the rheumatic diseases (01.06.2021)

Get full text

Journal Article

THU0191 JAK-STAT Pathway Stimulation, A New Cause of Inflammatory Arthritis

THU0191 JAK-STAT Pathway Stimulation, A New Cause of Inflammatory Arthritis

by Shaikh, M., Gilliver, R., Ostor, A.
Published in Annals of the rheumatic diseases (01.06.2016)

Get full text

Journal Article

Hypovitaminosis D among rheumatology outpatients in clinical practice

Hypovitaminosis D among rheumatology outpatients in clinical practice

by Mouyis, M., Ostor, A. J. K., Crisp, A. J., Ginawi, A., Halsall, D. J., Shenker, N., Poole, K. E. S.
Published in Rheumatology (Oxford, England) (01.09.2008)

Get full text

Journal Article

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

by Ding, Tina, Ledingham, Jo, Luqmani, Raashid, Westlake, Sarah, Hyrich, Kimme, Lunt, Mark, Kiely, Patrick, Bukhari, Marwan, Abernethy, Rikki, Bosworth, Ailsa, Ostor, Andrew, Gadsby, Kate, McKenna, Frank, Finney, Diana, Dixey, Josh, Deighton, Chris
Published in Rheumatology (Oxford, England) (01.11.2010)

Get full text

Journal Article

FRI0140 IMPACT OF BASELINE DEMOGRAPHICS AND DISEASE ACTIVITY ON OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB

FRI0140 IMPACT OF BASELINE DEMOGRAPHICS AND DISEASE ACTIVITY ON OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB

by Weinblatt, M., Mysler, E., Ostor, A., Broadwell, A., Jeka, S., Dunlap, K., Suboticki, J., Enejosa, J., Hendrickson, B., Zhong, S., Cherny, K., Wright, G.
Published in Annals of the rheumatic diseases (01.06.2020)

Get full text

Journal Article

FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial

FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial

by Edwards, C.J., Kiely, P., Ostor, A., Naisbett-Groet, B.
Published in Annals of the rheumatic diseases (01.06.2016)

Get full text

Journal Article

THU0190 Clinical outcomes among rheumatoid arthritis patients receiving adalimumab who did or did not participate in the patient support program: a subanalysis of the passion study

THU0190 Clinical outcomes among rheumatoid arthritis patients receiving adalimumab who did or did not participate in the patient support program: a subanalysis of the passion study

by Ostor, A., Wassenberg, S., Zueger, P., Kalabic, J., Wu, M., Lagunes Galindo, I., Van den Bosch, F.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

FRI0116 Impact of prior biologic use on treatment response in patients with rheumatoid arthritis receiving adalimumab in routine clinical care: results from the passion study

FRI0116 Impact of prior biologic use on treatment response in patients with rheumatoid arthritis receiving adalimumab in routine clinical care: results from the passion study

by Van den Bosch, F., Wassenberg, S., Zueger, P., Kalabic, J., Wu, M., Monastiriakos, K., Ostor, A.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

Clinical image: The Harlequin sign-benign blush or the bearer of bad news?

Clinical image: The Harlequin sign-benign blush or the bearer of bad news?

by Malaviya, Anshuman P., Ostor, A. J. K.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.07.2012)

Get full text

Journal Article

AB0262 Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis

AB0262 Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis

by van den Bosch, F., Wassenberg, S., Ostor, A., Varothai, N., Kalabic, J., Garg, V.
Published in Annals of the rheumatic diseases (01.06.2015)

Get full text

Journal Article

THU0097 Impact of Patient Support Program use on Clinical Outcomes Among Patients with Rheumatoid Arthritis

THU0097 Impact of Patient Support Program use on Clinical Outcomes Among Patients with Rheumatoid Arthritis

by van den Bosch, F., Wassenberg, S., Ostor, A., Varothai, N., Garg, V., Kalabic, J.
Published in Annals of the rheumatic diseases (01.06.2015)

Get full text

Journal Article

AB0693 Is there a link between vitamin d and juvenile idiopathic arthritis?

AB0693 Is there a link between vitamin d and juvenile idiopathic arthritis?

by Nisar, M., Cookson, P., Masood, F., Sansome, A., Ostor, A.
Published in Annals of the rheumatic diseases (01.06.2013)

Get full text

Journal Article

AB0692 What do we know about juvenile idiopathic arthritis and vitamin d? systematic literature review and meta-analysis of current evidence

AB0692 What do we know about juvenile idiopathic arthritis and vitamin d? systematic literature review and meta-analysis of current evidence

by Nisar, M., Cookson, P., Masood, F., Sansome, A., Ostor, A.
Published in Annals of the rheumatic diseases (01.06.2013)

Get full text

Journal Article

Pulsed low-intensity ultrasound therapy for chronic lateral epicondylitis: a randomized controlled trial

Pulsed low-intensity ultrasound therapy for chronic lateral epicondylitis: a randomized controlled trial

by D'Vaz, A. P., Ostor, A. J. K., Speed, C. A., Jenner, J. R., Bradley, M., Prevost, A. T., Hazleman, B. L.
Published in Rheumatology (Oxford, England) (01.05.2006)

Get full text

Journal Article

THU0223 The Novel CPLA2 Inhibitor AK106-001616 is a New Category of Anti-Inflammatory/Analgesic Drug Demonstrating Efficacy and Favorable Tolerability in the Treatment of Rheumatoid Arthritis

THU0223 The Novel CPLA2 Inhibitor AK106-001616 is a New Category of Anti-Inflammatory/Analgesic Drug Demonstrating Efficacy and Favorable Tolerability in the Treatment of Rheumatoid Arthritis

by Yamanishi, K., Ellis, B., Kudo, K., Kayanoki, T., Dews, I., Ostor, A., Wilson, A.
Published in Annals of the rheumatic diseases (01.06.2013)

Get full text

Journal Article

Interrater reproducibility of clinical tests for rotator cuff lesions

Interrater reproducibility of clinical tests for rotator cuff lesions

by Ostor, A J K, Richards, C A, Prevost, A T, Hazleman, B L, Speed, C A
Published in Annals of the rheumatic diseases (01.10.2004)

Get full text

Journal Article

The long road of biopharmaceutical drug development: from inception to marketing

The long road of biopharmaceutical drug development: from inception to marketing

by Mundae, M.K., Östör, A.J.K.
Published in QJM : An International Journal of Medicine (01.01.2010)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
Next
[10]